Details of the Drug

General Information of Drug (ID: DMCBIKO)

• Drug Name: ADCT-402

Indication

Disease Entry	ICD 11	Status	REF
Acute lymphoblastic leukaemia	2A85	Phase 1	[1]
B-cell non-hodgkin lymphoma	2B33.5	Phase 1	[1]
Burkitt cell leukaemia	2A85.6	Phase 1	[2]

• Cross-matching ID: TTD ID: D0HV4B
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)